These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19351847)

  • 1. Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease.
    Snook AE; Li P; Stafford BJ; Faul EJ; Huang L; Birbe RC; Bombonati A; Schulz S; Schnell MJ; Eisenlohr LC; Waldman SA
    Cancer Res; 2009 Apr; 69(8):3537-44. PubMed ID: 19351847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
    Snook AE; Stafford BJ; Li P; Tan G; Huang L; Birbe R; Schulz S; Schnell MJ; Thakur M; Rothstein JL; Eisenlohr LC; Waldman SA
    J Natl Cancer Inst; 2008 Jul; 100(13):950-61. PubMed ID: 18577748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.
    Snook AE; Magee MS; Marszalowicz GP; Schulz S; Waldman SA
    Cancer Immunol Immunother; 2012 May; 61(5):713-23. PubMed ID: 22057677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine adjuvanation of therapeutic anti-tumor immunity targeted to cancer mucosa antigens.
    Snook AE; Huang L; Schulz S; Eisenlohr LC; Waldman SA
    Clin Transl Sci; 2008 Dec; 1(3):263-4. PubMed ID: 19956776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.
    Snook AE; Magee MS; Schulz S; Waldman SA
    Eur J Immunol; 2014 Jul; 44(7):1956-66. PubMed ID: 24771148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8
    Xiang B; Baybutt TR; Berman-Booty L; Magee MS; Waldman SA; Alexeev VY; Snook AE
    J Immunol; 2017 May; 198(9):3507-3514. PubMed ID: 28341670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen.
    Snook AE; Eisenlohr LC; Rothstein JL; Waldman SA
    Clin Pharmacol Ther; 2007 Dec; 82(6):734-9. PubMed ID: 17898707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity.
    Okano F; Merad M; Furumoto K; Engleman EG
    J Immunol; 2005 Mar; 174(5):2645-52. PubMed ID: 15728471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.
    Lubbe WJ; Zuzga DS; Zhou Z; Fu W; Pelta-Heller J; Muschel RJ; Waldman SA; Pitari GM
    Cancer Res; 2009 Apr; 69(8):3529-36. PubMed ID: 19336567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex modulates intestinal transformation by the tumor-suppressor GCC.
    Li P; Schulz S; Pitari GM; Waldman SA
    Clin Transl Sci; 2008 Sep; 1(2):146-50. PubMed ID: 20443837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.
    Witek M; Blomain ES; Magee MS; Xiang B; Waldman SA; Snook AE
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1188-95. PubMed ID: 24661671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
    Carrithers SL; Barber MT; Biswas S; Parkinson SJ; Park PK; Goldstein SD; Waldman SA
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14827-32. PubMed ID: 8962140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope conservation and immunohistochemical localization of the guanylin/stable toxin peptide receptor, guanylyl cyclase C.
    Nandi A; Bhandari R; Visweswariah SS
    J Cell Biochem; 1997 Sep; 66(4):500-11. PubMed ID: 9282328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.
    Li P; Waldman SA
    Cancer Biol Ther; 2010 Aug; 10(3):211-8. PubMed ID: 20592492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?
    Li P; Lin JE; Marszlowicz GP; Valentino MA; Chang C; Schulz S; Pitari GM; Waldman SA
    Drug News Perspect; 2009; 22(6):313-8. PubMed ID: 19771320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A splice variant of the transcript for guanylyl cyclase C is expressed in human colon and colorectal cancer cells.
    Pearlman JM; Prawer SP; Barber MT; Parkinson SJ; Schulz S; Park J; Zook M; Waldman SA
    Dig Dis Sci; 2000 Feb; 45(2):298-305. PubMed ID: 10711442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can colorectal cancer be prevented or treated by oral hormone replacement therapy?
    Li P; Lin JE; Schulz S; Pitari GM; Waldman SA
    Curr Mol Pharmacol; 2009 Nov; 2(3):285-92. PubMed ID: 20021465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
    Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
    Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.